PMON72 The "RESCUE" Trial: 11beta-Hydroxysteroid Dehydrogenase Type 1 (HSD-1) Inhibition for ACTH-Dependent Cushing's Syndrome

BACKGROUND: HSD-1, an intracellular enzyme, converts cortisone to cortisol in tissues where cortisol excess is associated with morbidity including liver, adipose, bone, brain, muscle, skin, and eye. SPI-62 is a potent and specific HSD-1 inhibitor in development for treatment of Cushing's syndro...

Descripción completa

Detalles Bibliográficos
Autores principales: Czerwiec, Frank S, Drajesk, Jeffrey, Hooper, Sarah, Hunsicker, Kimberly, Jacks, Robert, MacPherson, Jamie, Marmon, Tonya, Katz, David A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Adrenal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627987/
http://dx.doi.org/10.1210/jendso/bvac150.179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627987/
http://dx.doi.org/10.1210/jendso/bvac150.179

Ejemplares similares